Qiagen NV | QIA - Net Income

Stock Price
43.18
Daily Change
-0.30 -0.69%
Monthly
1.92%
Yearly
8.88%
Q1 Forecast
43.53

Qiagen NV reported $130.04M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Alaunos Therapeutics USD -1.16M 417K Sep/2025
argenx SE USD 344.26M 98.9M Sep/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Dianthus Therapeutics USD -36.76M 5.13M Sep/2025
Ionis Pharmaceuticals USD -128.61M 252.16M Sep/2025
IQVIA Holdings USD 514M 183M Dec/2025
Moderna USD -200M 625M Sep/2025
Organon & Co USD 160M 15M Sep/2025
Qiagen NV USD 130.04M 33.79M Sep/2025
Revvity USD 46.65M 7.3M Sep/2025
Tectonic Therapeutic USD -19.04M 940K Sep/2025
Viatris USD -128.2M 123.6M Sep/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025